Abstract
Occupational lung disease (OLD) refers to a variety of disorders that affect the lungs following inhalation of dusts or chemical antigens in the work setting. OLD is an important public health issue and responsible for approximately 70% of all deaths from occupational diseases (Weston, IARC Sci Publ 163:387–405, 2011). Pneumoconioses comprise a subset of OLD that is defined as an interstitial lung disease caused by the inhalation of inorganic mineral dust. Other common work-related lung diseases include occupational asthma and hypersensitivity pneumonitis secondary to the exposure to dusts or antigens from a growing list of inciting agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Weston A. Work-related lung diseases. IARC Sci Publ. 2011;163:387–405.
Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science. 1993;262:242–4.
Stayner L, Welch LS, Lemen R. The worldwide pandemic of asbestos-related diseases. Annu Rev Public Health. 2013;34:205–16.
Guseva Canu I, Bateson TF, Bouvard V, et al. Human exposure to carbon-based fibrous nanomaterials: a review. Int J Hyg Environ Health. 2016;219:166–75.
Wagner GR. Asbestosis and silicosis. Lancet. 1997;349:1311–5.
Leung CC, Yu IT, Chen W. Silicosis. Lancet. 2012;379:2008–18.
American Thoracic Society Committee of the Scientific Assembly on Environmental and Occupational Health. Adverse effects of crystalline silica exposure. Am J Respir Crit Care Med. 1997;155:761–8.
De Vuyst P, Camus P. The past and present of pneumoconioses. Curr Opin Pulm Med. 2000;6:151–6.
Flynn MR, Susi P. Engineering controls for selected silica and dust exposures in the construction industry--a review. Appl Occup Environ Hyg. 2003;18:268–77.
Chong S, Lee KS, Chung MJ, et al. Pneumoconiosis: comparison of imaging and pathologic findings. Radiographics. 2006;26:59–77.
Champlin J, Edwards R, Pipavath S. Imaging of occupational lung disease. Radiol Clin N Am. 2016;54:1077–96.
Weil II, Jones RN, Parkes WR. Silicosis and related diseases. In: Parkes WR, editor. Occupational lung disorders. 3rd ed. London: Butterworths; 1994. p. 285–339.
Goodman GB, Kaplan PD, Stachura I, et al. Acute silicosis responding to corticosteroid therapy. Chest. 1992;101:366–70.
Marchiori E, Souza CA, Barbassa TG, et al. Silicoproteinosis: high-resolution CT findings in 13 patients. AJR Am J Roentgenol. 2007;189:1402–6.
Dee P, Suratt P, Winn W. The radiographic findings in acute silicosis. Radiology. 1978;126:359–63.
Marchiori E, Ferreira A, Müller NL. Silicoproteinosis: high-resolution CT and histologic findings. J Thorac Imaging. 2001;16:127–9.
Silicosis and Silicate Disease Committee. Diseases associated with exposure to silica and non-fibrous silicate minerals. Arch Pathol Lab Med. 1988;112:673–720.
Owens MW, Kinasewitz GT, Gonzalez E. Sandblaster’s lung with mycobacterial infection. Am J Med Sci. 1988;295:554–7.
Karkhanis VS, Joshi JM. Pneumoconioses. Indian J Chest Dis Allied Sci. 2013;55:25–34.
Buechner HA, Ansari A. Acute silico-proteinosis. A new pathologic variant of acute silicosis in sandblasters, characterized by histologic features resembling alveolar proteinosis. Dis Chest. 1969;55:274–8.
Rimal B, Greenberg AK, Rom WN. Basic pathogenetic mechanisms in silicosis: current understanding. Curr Opin Pulm Med. 2005;11:169–73.
Fujimura N. Pathology and pathophysiology of pneumoconiosis. Curr Opin Pulm Med. 2000;6:140–4.
Curran RC. Observations on the formation of collagen in quartz lesions. J Pathol Bacteriol. 1953;66:271–82.
Khalil N, Churg A, Muller N, et al. Environmental, inhaled and ingested causes of pulmonary fibrosis. Toxicol Pathol. 2007;35:86–96.
Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med. 1998;157:1666–80.
Hurley JF, Burns J, Copland L, et al. Coalworkers’ simple pneumoconiosis and exposure to dust at 10 British coalmines. Br J Ind Med. 1982;39:120–7.
Katabami M, Dosaka-Akita H, Honma K, et al. Pneumoconiosis-related lung cancers: preferential occurrence from diffuse interstitial fibrosis-type pneumoconiosis. Am J Respir Crit Care Med. 2000;162:295–300.
Federal Coal Mine Health and Safety Act of 1969. Pub L No. 1969;91–173.
Vallyathan V, Landsittel DP, Petsonk EL, et al. The influence of dust standards on the prevalence and severity of coal worker’s pneumoconiosis at autopsy in the United States of America. Arch Pathol Lab Med. 2011;135:1550–6.
Bergin CJ, Müller NL, Miller RR. CT in the qualitative assessment of emphysema. J Thorac Imaging. 1986;1:94–103.
Caplan A. Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax. 1953;8:29–37.
Hosgood HD 3rd, Chapman RS, Wei H, et al. Coal mining is associated with lung cancer risk in Xuanwei, China. Am J Ind Med. 2012;55:5–10.
Taeger D, Pesch B, Kendzia B, et al. Lung cancer among coal miners, ore miners and quarrymen: smoking-adjusted risk estimates from the synergy pooled analysis of case-control studies. Scand J Work Environ Health. 2015;41:467–77.
Fisher ER, Watkins G, Lam NV, et al. Objective pathological diagnosis of coal worker’s pneumoconiosis. JAMA. 1981;245:1829–34.
Kleinerman J, Green F, Harley RA, et al. Pathology standards for coal workers’ pneumoconiosis. Arch Pathol Lab Med. 1979;103:375–432.
Ross MH, Murray J. Occupational respiratory disease in mining. Occup Med (Lond). 2004;54:304–10.
Green FH, Laqueur WA. Coal workers’ pneumoconiosis. Pathol Annu. 1980;15:333–410.
Heppleston AG. The pathological recognition and pathogenesis of emphysema and fibrocystic disease of the lung with special reference to coal workers. Ann N Y Acad Sci. 1972;200:347–69.
Shennan DH, Washington JS, Thomas DJ, et al. Factors predisposing to the development of progressive massive fibrosis in coal miners. Br J Ind Med. 1981;38:321–6.
Churg AM, Green FHY. Occupational lung disease. In: Churg AM, Myers JL, Tazelaar HD, et al., editors. Thurlbeck’s pathology of the lung. 3rd ed. New York: Thieme; 2006. p. 788–800.
Ramazzini C. Asbestos is still with us: repeat call for a universal ban. Am J Ind Med. 2011;54:168–73.
Wagner JC, editor. Biological effects of mineral fibers. Lyon: IARC Press; 1979.
Stanton MF, Wrench C. Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst. 1972 Mar;48(3):797–821.
Stanton MF, Laynard M, Tegeris A, et al. Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst. 1977;58(3):587–603.
Pott F. Problems in defining carcinogenic fibres. Ann Occup Hyg. 1987;31:799–802.
Pott F, Huth F, Friedrichs KH. Tumorigenic effect of fibrous dusts in experimental animals. Environ Health Perspect. 1974;9:313–5.
Donovan EP, Donovan BL, McKinley MA, et al. Evaluation of take home (para-occupational) exposure to asbestos and disease: a review of the literature. Crit Rev Toxicol. 2012;42:703–31.
Rake C, Gilham C, Hatch J, et al. Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer. 2009;100:1175–83.
Ferrante D, Bertolotti M, Todesco A, et al. Cancer mortality and incidence of mesothelioma in a cohort of wives of asbestos workers in Casale Monferrato, Italy. Environ Health Perspect. 2007;115:1401–5.
Olsen NJ, Franklin PJ, Reid A, et al. Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation. Med J Aust. 2011;195:271–4.
Ahuja J, Kanne JP, Meyer CA. Occupational lung disease. Semin Roentgenol. 2015;50:40–51.
Lilis R, Lerman Y, Selikoff IJ. Symptomatic benign pleural effusions among asbestos insulation workers: residual radiographic abnormalities. Br J Ind Med. 1988;45:443–9.
Hillerdal G, Ozesmi M. Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis. 1987;71:113–21.
Epler GR, McLoud TC, Gaensler EA. Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA. 1982;247:617–22.
Akira M. High-resolution CT in the evaluation of occupational and environmental disease. Radiol Clin N Am. 2002;40:43–59.
Munden RF, Libshitz HI. Rounded atelectasis and mesothelioma. AJR Am J Roentgenol. 1998;170:1519–22.
McLoud TC, Woods BO, Carrington CB, et al. Diffuse pleural thickening in an asbestos-exposed population: prevalence and causes. AJR Am J Roentgenol. 1985;144:9–18.
Wagner JC, Moncrieff CB, Coles R, et al. Correlation between fibre content of the lungs and disease in naval dockyard workers. Br J Ind Med. 1986;43:391–5.
Roggli VL, Longo WE. Mineral fiber content of lung tissue in patients with environmental exposures: household contacts vs. building occupants. Ann N Y Acad Sci. 1991;643:511–8.
Lazarus AA, Philip A. Asbestosis. Dis Mon. 2011;57:14–26.
Sirajuddin A, Kanne JP. Occupational lung disease. J Thorac Imaging. 2009;24:310–20.
Roach HD, Davies GJ, Attanoos R, et al. Asbestos: when the dust settles an imaging review of asbestos-related disease. Radiographics. 2002;22:S167–84.
Lynch DA, Gamsu G, Aberle DR. Conventional and high resolution computed tomography in the diagnosis of asbestos-related diseases. Radiographics. 1989;9:523–51.
Akira M, Yamamoto S, Inoue Y, et al. High-resolution CT of asbestosis and idiopathic pulmonary fibrosis. AJR Am J Roentgenol. 2003;181:163–9.
Henderson DW, Rödelsperger K, Woitowitz HJ, et al. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997–2004. Pathology. 2004;36:517–50.
Attanoos RL. Asbestos-related lung disease. Surg Pathol Clin. 2010;3:109–27.
Roggli VL, Gibbs AR, Attanoos R, et al. Pathology of asbestosis- an update of the diagnostic criteria: report of the asbestosis committee of the College of American Pathologists and Pulmonary Pathology Society. Arch Pathol Lab Med. 2010;134:462–80.
Chapman SJ, Cookson WO, Musk AW, et al. Benign asbestos pleural diseases. Curr Opin Pulm Med. 2003;9:266–71.
Huggins JT, Sahn SA. Causes and management of pleural fibrosis. Respirology. 2004;9:441–7.
Menzies R, Fraser R. Round atelectasis. Pathologic and pathogenetic features. Am J Surg Pathol. 1987;11:674–81.
Stephens M, Gibbs AR, Pooley FD, et al. Asbestos induced diffuse pleural fibrosis: pathology and mineralogy. Thorax. 1987;42:583–8.
Craighead JE, Abraham JL, Churg A, et al. The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med. 1982;106:544–96.
Sporn TA, Roggli VL. In: Roggli VL, Oury TD, Sporn TA, editors. Pathology of asbestos-associated diseases. 2nd ed. New York: Springer; 2004. p. 71–103.
Roggli VL. Scanning electron microscopic analysis of mineral fiber content of lung tissue in the evaluation of diffuse pulmonary fibrosis. Scanning Microsc. 1991;5:71–80.
Gaensler EA, Jederlinic PJ, Churg A. Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis. 1991;144:689–96.
Wagner JC, Newhouse ML, Corrin B, et al. Correlation between fibre content of the lung and disease in east London asbestos factory workers. Br J Ind Med. 1988;45:305–8.
Ashcroft T, Heppleston AG. The optical and electron microscopic determination of pulmonary asbestos fibre concentration and its relation to the human pathological reaction. J Clin Pathol. 1973;26:224–34.
Roggli VL. Asbestos bodies and non-asbestos ferruginous bodies. In: Roggli VL, Oury TD, Sporn TA, editors. Pathology of asbestos-associated diseases. 2nd ed. New York: Springer; 2004. p. 34–70.
De Vuyst P, Dumortier P, Gevenois PA. Analysis of asbestos bodies in BAL from subjects with particular exposures. Am J Ind Med. 1997;31:699–704.
Honma K, Abraham JL, Chiyotani K, et al. Proposed criteria for mixed-dust pneumoconiosis: definition, descriptions, and guidelines for pathologic diagnosis and clinical correlation. Hum Pathol. 2004;35:1515–23.
Coates EO Jr, Watson JH. Diffuse interstitial lung disease in tungsten carbide workers. Ann Intern Med. 1971;75:709–16.
Barceloux DG. Cobalt. J Toxicol Clin Toxicol. 1999;37:201–6.
Payne LR. Manufacturing processes: hard metal. J Soc Occup Med. 1976;26:141–2.
Nemery B, Verbeken EK, Demedts M. Giant cell interstitial pneumonia (hard metal lung disease, cobalt lung). Semin Respir Crit Care Med. 2001;22:435–48.
Naqvi AH, Hunt A, Burnett BR, et al. Pathologic spectrum and lung dust burden in giant cell interstitial pneumonia (hard metal disease/cobalt pneumonitis): review of 100 cases. Arch Environ Occup Health. 2008;63:51–70.
Demedts M, Gheysens B, Nagels J, et al. Cobalt lung in diamond polishers. Am Rev Respir Dis. 1984;130:130–5.
Nemery B, Abraham JL. Hard metal lung disease: still hard to understand. Am J Respir Crit Care Med. 2007;176:2–3.
Nemery B, Casier P, Roosels D, et al. Survey of cobalt exposure and respiratory health in diamond polishers. Am Rev Respir Dis. 1992;145:610–6.
Maier LA, Glazer C, Pacheco K. Interstitial lung disease and other occupational exposures (hard metal lung disease). In: Schwartz M, King T, editors. Interstitial lung disease. 5th ed. China: People’s Medical Publishing House; 2011. p. 581–93.
Anttila S, Sutinen S, Paananen M, et al. Hard metal lung disease: a clinical, histological, ultrastructural and X-ray microanalytical study. Eur J Respir Dis. 1986;69:83–94.
Bruckner HC. Extrinsic asthma in a tungsten carbide worker. J Occup Med. 1967;9:518–9.
Davison AG, Haslam PL, Corrin B, et al. Interstitial lung disease and asthma in hard-metal workers: bronchoalveolar lavage, ultrastructural, and analytical findings and results of bronchial provocation tests. Thorax. 1983;38:119–28.
Forrest ME, Skerker LB, Nemiroff MJ. Hard metal pneumoconiosis: another cause of diffuse interstitial fibrosis. Radiology. 1978;128:609–12.
Gheysens B, Auwerx J, Van den Eeckhout A, et al. Cobalt-induced bronchial asthma in diamond polishers. Chest. 1985;88:740–4.
Sjögren I, Hillerdal G, Andersson A, et al. Hard metal lung disease: importance of cobalt in coolants. Thorax. 1980;35:653–9.
Liebow AA, Carrington CB. The interstitial pneumonias. In: Simon M, Potchen EJ, LeMay M, editors. Frontiers of pulmonary radiology. 1st ed. New York: Grune & Stratton; 1969. p. 102–41.
Katzenstein AL, Myers JL. Nonspecific interstitial pneumonia and the other idiopathic interstitial pneumonias: classification and diagnostic criteria. Am J Surg Pathol. 2000;24:1–3.
Joseph M. Hard metal pneumoconiosis. Australas Radiol. 1968;12:92–5.
Balmes JR. Respiratory effects of hard-metal dust exposure. Occup Med. 1987;2:327–44.
Cugell DW, Morgan WK, Perkins DG, et al. The respiratory effects of cobalt. Arch Intern Med. 1990;150:177–83.
Ohori NP, Sciurba FC, Owens GR, et al. Giant-cell interstitial pneumonia and hard-metal pneumoconiosis. A clinicopathologic study of four cases and review of the literature. Am J Surg Pathol. 1989;13:581–7.
Coates EO Jr, Watson JH. Pathology of the lung in tungsten carbide workers using light and electron microscopy. J Occup Med. 1973;15:280–6.
Akira M. Uncommon pneumoconioses: CT and pathologic findings. Radiology. 1995;197:403–9.
Choi JW, Lee KS, Chung MP, et al. Giant cell interstitial pneumonia: high-resolution CT and pathologic findings in four adult patients. AJR Am J Roentgenol. 2005;184:268–72.
Ruokonen EL, Linnainmaa M, Seuri M, et al. A fatal case of hard-metal disease. Scand J Work Environ Health. 1996;22:62–5.
Maier LA. Clinical approach to chronic beryllium disease and other nonpneumoconiotic interstitial lung diseases. J Thorac Imaging. 2002;17:273–84.
Nureki S, Miyazaki E, Nishio S, et al. Hard metal lung disease successfully treated with inhaled corticosteroids. Intern Med. 2013;52:1957–61.
Tarabichi Y, Saggar R, Wallace WD, et al. Primary disease recurrence after single lung transplantation in a patient with prior hard metal exposure. J Heart Lung Transplant. 2015;34:1216–8.
Alexandersson R. Blood and urinary concentrations as estimators of cobalt exposure. Arch Environ Health. 1988;43:299–303.
Forni A. Bronchoalveolar lavage in the diagnosis of hard metal disease. Sci Total Environ. 1994;150:69–76.
Kinoshita M, Sueyasu Y, Watanabe H, et al. Giant cell interstitial pneumonia in two hard metal workers: the role of bronchoalveolar lavage in diagnosis. Respirology. 1999;4:263–6.
Adams TN, Butt YM, Batra K, et al. Cobalt related interstitial lung disease. Respir Med. 2017;129:91–7.
Delage G, Brochu P, Robillard L, et al. Giant cell pneumonia due to respiratory syncytial virus. Occurrence in severe combined immunodeficiency syndrome. Arch Pathol Lab Med. 1984;108:623–5.
Weintrub PS, Sullender WM, Lombard C, et al. Giant cell pneumonia caused by parainfluenza type 3 in a patient with acute myelomonocytic leukemia. Arch Pathol Lab Med. 1987;111:569–70.
Stewart MJ, Faulds JS. The pulmonary fibrosis of haematite workers. J Pathol. 1934;39:233–53.
Theodos PA, Cathart RT, Fraimow W. Ischemic necrosis in anthracosilicosis. Arch Environ Health. 1961;2:609–19.
Dreesen WC, Jones RR. Anthracosilicosis. J Am Med Assoc. 1936;107:1179–85.
Uehlinger E. Über Mischstaubpneumokoniosen. Pathobiology. 1946;9:692–700.
Shida H, Chiyotani K, Honma K, et al. Radiologic and pathologic characteristics of mixed dust pneumoconiosis. Radiographics. 1996;16:483–98.
Lange BA, Haartz JC. Determination of microgram quantities asbestos by x-ray diffraction: chrysotile in thin dust layers of matrix material. Anal Chem. 1979;51:520–5.
Kohyama N. A new X-ray diffraction method for the quantitative analysis of free silica in the airborne dust in working environment. Ind Health. 1985;23:221–34.
Abraham JL, Burnett BR, Hunt A. Development and use of a pneumoconiosis database of human pulmonary inorganic particulate burden in over 400 lungs. Scanning Microsc. 1991;5:95–104.
Lang L. Beryllium: a chronic problem. Environ Health Perspect. 1994;102:526–31.
Meyer KC. Beryllium and lung disease. Chest. 1994;106:942–6.
Ordstrand HV, Hughes R, Carmody MG. Chemical pneumonia in workers extracting beryllium oxide: report of three cases. Cleve Clin Q. 1943;10:10–8.
Weber HH, Engelhardt WE. Über eine Apparatur zur Erzeugung niedriger Staubkonzentrationen von großer Konstanz und eine Methode zur mikrogravimetrischen Staubbestimmung. In: Anwendung bei der Untersuchung von Stauben aus der Berylliumgewinnung, vol 10; 1933, p. 41.
Freiman DG, Hardy HL. Beryllium disease. The relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. beryllium case registry. Hum Pathol. 1970;1:25–44.
Eisenbud M, Berghout CF, Steadman LT. Environmental studies in plants and laboratories using beryllium; the acute disease. J Ind Hyg Toxicol. 1948;30:281–5.
Occupational Safety and Health Administration. Beryllium: proposed occupational safety and health standard. Fed Regist. 1975;40:48814–27.
Infante PF, Newman LS. Beryllium exposure and chronic beryllium disease. Lancet. 2004;363:415–6.
Kriebel D, Brain JD, Sprince NL, et al. The pulmonary toxicity of beryllium. Am Rev Respir Dis. 1988;137:464–73.
Maceira JM, Fukuyama K, Epstein WL, et al. Immunohistochemical demonstration of S-100 protein antigen-containing cells in beryllium-induced, zirconium-induced and sarcoidosis granulomas. Am J Clin Pathol. 1984;81:563–8.
Kreiss K, Wasserman S, Mroz MM, et al. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. J Occup Med. 1993;35:267–74.
Kreiss K, Mroz MM, Zhen B, et al. Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis. 1993;148:985–91.
De Nardi JM, Van Ordstrand HS, Curtis GH. Berylliosis. Summary and survey of all clinical types in ten year period. Cleve Clin Q. 1952;19:171–93.
Kelleher PC, Martyny JW, Mroz MM, et al. Beryllium particulate exposure and disease relations in a beryllium machining plant. J Occup Environ Med. 2001;43:238–49.
Eisenbud M, Lisson J. Epidemiological aspects of beryllium-induced nonmalignant lung disease: a 30-year update. J Occup Med. 1983;25:196–202.
Sprince NL, Kanarek DJ, Weber AL, et al. Reversible respiratory disease in beryllium workers. Am Rev Respir Dis. 1978;117:1011–7.
Mayer AS, Hamzeh N, Maier LA. Sarcoidosis and chronic beryllium disease: similarities and differences. Semin Respir Crit Care Med. 2014;35:316–29.
Harris KM, McConnochie K, Adams H. The computed tomographic appearances in chronic berylliosis. Clin Radiol. 1993;47:26–31.
Newman LS, Buschman DL, Newell JD Jr, et al. Beryllium disease: assessment with CT. Radiology. 1994;190:835–40.
Sood A, Beckett WS, Cullen MR. Variable response to long-term corticosteroid therapy in chronic beryllium disease. Chest. 2004;126:2000–7.
Steenland K, Ward E. Lung cancer incidence among patients with beryllium disease: a cohort mortality study. J Natl Cancer Inst. 1991;83:1380–5.
Williams WJ. A histological study of the lungs in 52 cases of chronic beryllium disease. Br J Ind Med. 1958;15:84–91.
Butnor KJ, Sporn TA, Ingram P, et al. Beryllium detection in human lung tissue using electron probe X-ray microanalysis. Mod Pathol. 2003;16:1171–7.
Newman LS. Significance of the blood beryllium lymphocyte proliferation test. Environ Health Perspect. 1996;104:953–6.
Nam K, Gracey DR. Pulmonary talcosis from cosmetic talcum powder. JAMA. 1972;221:492–3.
Gibbs AE, Pooley FD, Griffiths DM, et al. Talc pneumoconiosis: a pathologic and mineralogic study. Hum Pathol. 1992;23:1344–54.
Abraham JL, Brambilla C. Particle size for differentiation between inhalation and injection pulmonary talcosis. Environ Res. 1980;21:94–6.
Feigin DS. Talc: understanding its manifestations in the chest. AJR Am J Roentgenol. 1986;146:295–301.
Lockey JE. Nonasbestos fibrous minerals. Clin Chest Med. 1981;2:203–18.
Ward S, Heyneman LE, Reittner P, et al. Talcosis associated with IV abuse of oral medications: CT findings. AJR Am J Roentgenol. 2000;174:789–93.
Marchiori E, Lourenço S, Gasparetto TD, et al. Pulmonary talcosis: imaging findings. Lung. 2010;188:165–71.
Gysbrechts C, Michiels E, Verbeken E, et al. Interstitial lung disease more than 40 years after a 5 year occupational exposure to talc. Eur Respir J. 1998;11:1412–5.
Hughes WT. Acute upper respiratory tract infections in children. GP. 1966;34:102–8.
Krimsky WS, Dhand S. Pulmonary talc granulomatosis mimicking malignant disease 30 years after last exposure: a case report. J Med Case Rep. 2008;2:225.
Padley SP, Adler BD, Staples CA, et al. Pulmonary talcosis: CT findings in three cases. Radiology. 1993;186:125–7.
Ben-Haim SA, Ben-Ami H, Edoute Y, et al. Talcosis presenting as pulmonary infiltrates in an HIV-positive heroin addict. Chest. 1988;94:656–8.
Stern EJ, Frank MS, Schmutz JF, et al. Panlobular pulmonary emphysema caused by i.v. injection of methylphenidate (Ritalin): findings on chest radiographs and CT scans. AJR Am J Roentgenol. 1994;162:555–60.
Marchiori E, Souza Júnior AS, Müller NL. Inhalational pulmonary talcosis: high-resolution CT findings in 3 patients. J Thorac Imaging. 2004;19:41–4.
Marchiori E, Franquet T, Gasparetto TD, et al. Consolidation with diffuse or focal high attenuation: computed tomography findings. J Thorac Imaging. 2008;23:298–304.
Chau CH, Yew WW, Lee J. Inhaled budesonide in the treatment of talc-induced pulmonary granulomatosis. Respiration. 2003;70:439.
Doese M. Injuries to health caused by aluminium and particularly the effect of aluminium dust on the lungs. Arch f Gewerbepath u Gewerbehyg. 1938;8:501–31.
Gilks B, Churg A. Aluminum-induced pulmonary fibrosis: do fibers play a role? Am Rev Respir Dis. 1987;136:176–9.
Townsend MC, Sussman NB, Enterline PE, et al. Radiographic abnormalities in relation to total dust exposure at a bauxite refinery and alumina-based chemical products plant. Am Rev Respir Dis. 1988;138:90–5.
Dinman BD. Aluminum in the lung: the pyropowder conundrum. J Occup Med. 1987;29:869–76.
Guidotti TL. Pulmonary aluminosis—a review. Bull Soc Pharmacol Environ Pathol. 1975;3:16–8.
Kelleher P, Pacheco K, Newman LS. Inorganic dust pneumonias: the metal-related parenchymal disorders. Environ Health Perspect. 2000;108:685–96.
Krewski D, Yokel RA, Nieboer E, et al. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J Toxicol Environ Health B Crit Rev. 2007;10:1–269.
De Vuyst P, Dumortier P, Rickaert F, et al. Occupational lung fibrosis in an aluminium polisher. Eur J Respir Dis. 1986;68:131–40.
Kraus T, Schaller KH, Angerer J, et al. Aluminosis--detection of an almost forgotten disease with HRCT. J Occup Med Toxicol. 2006;1:4.
Goralewski G. The aluminium lung: a new industrial disease. Br J Ind Med. 1948;6:53–4.
Jederlinic PJ, Abraham JL, Churg A, et al. Pulmonary fibrosis in aluminum oxide workers. Investigation of nine workers, with pathologic examination and microanalysis in three of them. Am Rev Respir Dis. 1990;142:1179–84.
Edling NP. Aluminium pneumoconiosis. A roentgendiagnostic study of five cases. Acta Radiol. 1961;56:170–8.
Mitchell J, Manning GB, Molyneux M, et al. Pulmonary fibrosis in workers exposed to finely powdered aluminium. Br J Ind Med. 1961;18:10–23.
Chen WJ, Monnat RJ Jr, Chen M, et al. Aluminum induced pulmonary granulomatosis. Hum Pathol. 1978;9:705–11.
Chino H, Hagiwara E, Sugisaki M, et al. Pulmonary aluminosis diagnosed with in-air microparticle induced X-ray emission analysis of particles. Intern Med. 2015;54:2035–40.
Guidotti TL, Abraham JL, DeNee PB, et al. Arc welders’ pneumoconiosis: application of advanced scanning electron microscopy. Arch Environ Health. 1978;33:117–24.
Yoshii C, Matsuyama T, Takazawa A, et al. Welder’s pneumoconiosis: diagnostic usefulness of high-resolution computed tomography and ferritin determinations in bronchoalveolar lavage fluid. Intern Med. 2002;41:1111–7.
Cosgrove MP. Pulmonary fibrosis and exposure to steel welding fume. Occup Med (Lond). 2015;65:706–12.
Harding HE, Grout JL, Davies TL. The experimental production of x-ray shadows in the lungs by inhalation of industrial dusts: I. Iron oxide. Br J Ind Med. 1947;4:223.
Harding HE, McLaughlin AI, Doig AT. Clinical, radiographic, and pathological studies of the lungs of electric-arc and oxyacetylene welders. Lancet. 1958;2:394–9.
Müller KM, Verhoff MA. Gradation of sideropneumoconiosis. Pneumologie. 2000;54:315–7.
Hicks R, Al-Shamma KJ, Lam HF, et al. An investigation of fibrogenic and other toxic effects of arc-welding fume particles deposited in the rat lung. J Appl Toxicol. 1983;3:297–306.
Yu IJ, Song KS, Chang HK, et al. Lung fibrosis in Sprague-Dawley rats, induced by exposure to manual metal arc-stainless steel welding fumes. Toxicol Sci. 2001;63:99–106.
Buerke U, Schneider J, Rösler J, et al. Interstitial pulmonary fibrosis after severe exposure to welding fumes. Am J Ind Med. 2002;41:259–68.
Flors L, Domingo ML, Leiva-Salinas C, et al. Uncommon occupational lung diseases: high-resolution CT findings. AJR Am J Roentgenol. 2010;194:W20–6.
Billings CG, Howard P. Occupational siderosis and welders’ lung: a review. Monaldi Arch Chest Dis. 1993;48:304–14.
Roub LW, Dekker A, Wagenblast HW, et al. Pulmonary silicatosis. A case diagnosed by needle-aspiration biopsy and energy-dispersive x-ray analysis. Am J Clin Pathol. 1979;72:871–5.
Skulberg KR, Gylseth B, Skaug V, et al. Mica pneumoconiosis--a literature review. Scand J Work Environ Health. 1985;11:65–74.
Davies D, Cotton R. Mica pneumoconiosis. Br J Ind Med. 1983;40:22–7.
Morgan WK, Donner A, Higgins IT, et al. The effects of kaolin on the lung. Am Rev Respir Dis. 1988;138:813–20.
Lapenas D, Gale P, Kennedy T, et al. Kaolin pneumoconiosis. Radiologic, pathologic, and mineralogic findings. Am Rev Respir Dis. 1984;130:282–8.
Wagner JC, Pooley FD, Gibbs A, et al. Inhalation of China stone and China clay dusts: relationship between the mineralogy of dust retained in the lungs and pathological changes. Thorax. 1986;41:190–6.
Landas SK, Schwartz DA. Mica-associated pulmonary interstitial fibrosis. Am Rev Respir Dis. 1991;144:718–21.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Weissferdt, A. (2020). Occupational Lung Disease. In: Diagnostic Thoracic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-36438-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-36438-0_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-36437-3
Online ISBN: 978-3-030-36438-0
eBook Packages: MedicineMedicine (R0)